These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24832468)

  • 1. Phage display discovery of novel molecular targets in glioblastoma-initiating cells.
    Liu JK; Lubelski D; Schonberg DL; Wu Q; Hale JS; Flavahan WA; Mulkearns-Hubert EE; Man J; Hjelmeland AB; Yu J; Lathia JD; Rich JN
    Cell Death Differ; 2014 Aug; 21(8):1325-39. PubMed ID: 24832468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue.
    Ruiz-Ontañon P; Orgaz JL; Aldaz B; Elosegui-Artola A; Martino J; Berciano MT; Montero JA; Grande L; Nogueira L; Diaz-Moralli S; Esparís-Ogando A; Vazquez-Barquero A; Lafarga M; Pandiella A; Cascante M; Segura V; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL
    Stem Cells; 2013 Jun; 31(6):1075-85. PubMed ID: 23401361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
    J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.
    Wang H; Sun T; Hu J; Zhang R; Rao Y; Wang S; Chen R; McLendon RE; Friedman AH; Keir ST; Bigner DD; Li QJ; Wang H; Wang XF
    J Clin Invest; 2014 Oct; 124(10):4489-502. PubMed ID: 25202981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.
    Kim J; Potez M; She C; Huang P; Wu Q; Bao S; Rich JN; Liu JKC
    Stem Cells; 2023 Aug; 41(8):762-774. PubMed ID: 37280108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
    Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT
    PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eva1 Maintains the Stem-like Character of Glioblastoma-Initiating Cells by Activating the Noncanonical NF-κB Signaling Pathway.
    Ohtsu N; Nakatani Y; Yamashita D; Ohue S; Ohnishi T; Kondo T
    Cancer Res; 2016 Jan; 76(1):171-81. PubMed ID: 26677976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
    Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
    Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
    Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
    Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial Heterogeneity of Invading Glioblastoma Cells Regulated by Paracrine Factors.
    Chonan Y; Yamashita T; Sampetrean O; Saya H; Sudo R
    Tissue Eng Part A; 2022 Jul; 28(13-14):573-585. PubMed ID: 34841881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
    Hasan T; Caragher SP; Shireman JM; Park CH; Atashi F; Baisiwala S; Lee G; Guo D; Wang JY; Dey M; Wu M; Lesniak MS; Horbinski CM; James CD; Ahmed AU
    Cell Death Dis; 2019 Mar; 10(4):292. PubMed ID: 30926789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy.
    Zhuang W; Long L; Zheng B; Ji W; Yang N; Zhang Q; Liang Z
    Cancer Sci; 2012 Apr; 103(4):684-90. PubMed ID: 22192169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VAV3 regulates glioblastoma cell proliferation, migration, invasion and cancer stem‑like cell self‑renewal.
    Miao R; Huang D; Zhao K; Li Y; Zhang X; Cheng Y; Guo N
    Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36960857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
    Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells.
    Echizenya S; Ishii Y; Kitazawa S; Tanaka T; Matsuda S; Watanabe E; Umekawa M; Terasaka S; Houkin K; Hatta T; Natsume T; Maeda Y; Watanabe SI; Hagiwara S; Kondo T
    Neuro Oncol; 2020 Feb; 22(2):229-239. PubMed ID: 31499527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity.
    Zhuang W; Li B; Long L; Chen L; Huang Q; Liang Z
    Int J Cancer; 2011 Dec; 129(11):2720-31. PubMed ID: 21384342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
    López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
    Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.